» Articles » PMID: 26315116

Characterization of the Cellular Infiltrate in Bioprosthetic Heart Valves Explanted from Patients with Structural Valve Deterioration

Overview
Specialty General Surgery
Date 2015 Aug 29
PMID 26315116
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prevention by the CXCR2 antagonist SCH527123 of the calcification of porcine heart valve cusps implanted subcutaneously in rats.

Chabry Y, Dhayni K, Kamel S, Caus T, Bennis Y Front Cardiovasc Med. 2023; 10:1227589.

PMID: 37781314 PMC: 10540224. DOI: 10.3389/fcvm.2023.1227589.


Soft Biomimetic Approach for the Development of Calcinosis-Resistant Glutaraldehyde-Fixed Biomaterials for Cardiovascular Surgery.

Zvyagina A, Minaychev V, Kobyakova M, Lomovskaya Y, Senotov A, Pyatina K Biomimetics (Basel). 2023; 8(4).

PMID: 37622962 PMC: 10452421. DOI: 10.3390/biomimetics8040357.


Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification.

Wen S, Zhou Y, Yim W, Wang S, Xu L, Shi J Front Pharmacol. 2022; 13:909801.

PMID: 35721165 PMC: 9204043. DOI: 10.3389/fphar.2022.909801.


Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.

Higuita M, Griffiths L Acta Biomater. 2020; 107:115-128.

PMID: 32151701 PMC: 7164717. DOI: 10.1016/j.actbio.2020.03.003.


Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Higuita M, Griffiths L Tissue Eng Part B Rev. 2019; 26(1):26-45.

PMID: 31663438 PMC: 7041331. DOI: 10.1089/ten.TEB.2019.0229.